Pharmacological inhibition of asparaginyl endopeptidase by δ-secretase inhibitor 11 mitigates Alzheimer’s disease-related pathologies in a senescence-accelerated mouse model
Ju Wang(Jinan University), Mingke Song(Shanghai Jiao Tong University)
Cited by 22
Related Papers
BMP-2 induces EMT and breast cancer stemness through Rb and CD44
|Cell Death Discovery|2017|89
The <scp>TRPC</scp> channel blocker <scp>SKF</scp> 96365 inhibits glioblastoma cell growth by enhancing reverse mode of the <scp><scp>Na<sup>+</sup></scp></scp>/<scp><scp>Ca<sup>2+</sup></scp></scp> exchanger and increasing intracellular <scp><scp>Ca<sup>2+</sup></scp></scp>
|British Journal of Pharmacology|2014|61
Blockade of the forward Na<sup>+</sup>/Ca<sup>2+</sup> exchanger suppresses the growth of glioblastoma cells through Ca<sup>2+</sup>‐mediated cell death
|British Journal of Pharmacology|2019|44
Pharmacological Inhibition of the Asparaginyl Endopeptidase (AEP) in an Alzheimer’s Disease Model Improves the Survival and Efficacy of Transplanted Neural Stem Cells
|International Journal of Molecular Sciences|2023|11